PubRank

Andrzej Kurylak

Author PubWeight™ 8.12‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Healthcare-associated infections in a neonatal intensive care unit. Arch Med Sci 2012 0.87
2 Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia. J Cancer Res Clin Oncol 2007 0.87
3 Activation of NF-ĸB in leukemic cells in response to initial prednisone therapy in children with acute lymphoblastic leukaemia: relation to other prognostic factors. Pol J Pathol 2011 0.86
4 [Characteristics of extracranial malignant germ cell tumours in two age groups of children (0-10 and 10-18 years). Multicentre experiences]. Med Wieku Rozwoj 2011 0.81
5 Cytotoxicity of cortivazol in childhood acute lymphoblastic leukemia. Anticancer Res 2005 0.80
6 Health-related quality of life among paediatric survivors of primary brain tumours and acute leukaemia. Qual Life Res 2010 0.80
7 [Passive smoking and frequency of occurrence of disease symptoms in the respiratory system in children aged 0-7]. Przegl Lek 2006 0.79
8 Simultaneous assessment of p53 and MDM2 expression in leukemic cells in response to initial prednisone therapy in children with acute lymphoblastic leukemia. Pol J Pathol 2010 0.79
9 Thymic carcinoma in children: a report from the Polish Pediatric Rare Tumors Study. Pediatr Blood Cancer 2010 0.78
10 [Results of immunosuppressive therapy in children with severe aplastic anaemia. Report by the Polish Paediatric Leukaemia and Lymphoma Study Group]. Med Wieku Rozwoj 2007 0.77
11 Renal function and low-molecular-weight proteins (cystatin C, β2-microglobulin, neutrophil gelatinase-associated lipocalin) in child and young adult cancer survivors. J Pediatr Hematol Oncol 2012 0.75
12 Factors predicting survival in childhood malignant and intermediate vascular tumors : retrospective analysis of the Polish and German cooperative paediatric soft tissue sarcoma study groups and review of the literature. Ann Surg Oncol 2010 0.75
13 The influence of intracellular idarubicin and daunorubicin levels on drug cytotoxicity in childhood acute leukemia. Acta Biochim Pol 2002 0.75
14 [Soft tissue sarcomas of bladder and prostate in children treated according to the CWS-96 protocol--report of the Polish Paediatric Solid Tumours Study Group]. Med Wieku Rozwoj 2006 0.75
15 Decrease of dual hepatitis B and C virus infections in children with cancer: changes in risk factors over 30 years. Haematologica 2004 0.75
16 [Results of immunosupressive therapy in children with severe aplastic anaemia. Report of the Polish Paediatric Haematology Group]. Med Wieku Rozwoj 2009 0.75
17 [Soft tissue sarcoma of the bladder and prostate. A report of the Polish Paediatric Solid Tumour Group (PPSTG)]. Med Wieku Rozwoj 2005 0.75
18 Accumulation of Tc-99m DTPA in Ewing sarcoma. Clin Nucl Med 2005 0.75
19 [Malignant vascular tumours in children -- report from the Polish Pediatric Rare Tumors Study]. Med Wieku Rozwoj 2005 0.75
20 [Genitourinary soft tissue sarcomas located outside bladder and prostate in children treated according to the CWS-96 protocol--report from the Polish Paediatric Solid Tumours Study Group]. Med Wieku Rozwoj 2006 0.75
21 [Prophylactic use of hematopoietic growth factors (G-CSF, GM-CSF) in prevention of chemotherapy-induced myelosuppression in children]. Wiad Lek 2003 0.75
22 In vitro activity of glufosfamide in childhood acute leukemia. Anticancer Res 2002 0.75
23 [Pain in hospitalized teenagers suffering from neoplastic disease. Preliminary report]. Ann Acad Med Stetin 2010 0.75
24 [Imatinib mesylate in treatment of childhood chronic myeloid leukaemia. Preliminary report]. Med Wieku Rozwoj 2007 0.75
25 The role of radioisotopic methods in imaging of intervertebral disc inflammation in children. Nucl Med Rev Cent East Eur 2006 0.75
26 [Thymoma and thymic carcinoma--review of literature and clinical characteristics based on the Polish Paediatric Solid Tumours Study Group experience]. Med Wieku Rozwoj 2008 0.75
27 [Rare tumours--are they really rare in the Polish children population?]. Przegl Lek 2004 0.75